Journal: Disabled World. Language: English. Last Revised Publication Date: 2018/07/03. Reference Title: "U.S. FDA New Drug and Product Approvals", Abstract: Disabled World archive digest of 68 FDA Approvals papers, documents, and publications - DW#CAT2-0T7-347
Although some of these documents from our FDA Approvals category may have since been updated, or revised, they are sorted below by their original publish date order - the most recent publications first.
1 - Generic Version of EpiPen Approved by U.S. FDA | 2018/08/19
2 - Scammers Target Consumers with Fake FDA Warning Letters | 2018/07/13
3 - FDA Approves Glucose Monitoring System with Sensor and App for Adults with Diabetes | 2018/06/21
4 - Automated Insulin Delivery and Monitoring System for Younger Pediatric Patients Approved by FDA | 2018/06/21
5 - US FDA Authorizes First Fully Interoperable Continuous Glucose Monitoring System | 2018/03/29
6 - Statement From FDA Commissioner on Steps to Facilitate Efficient Generic Drug Review to Enhance Competition, Promote Access and Lower Drug Prices | 2018/01/03
7 - FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers | 2017/12/28
8 - U.S. FDA Approves Gene Therapy for Treatment of Cancer and Life-threatening Diseases | 2017/09/22
9 - U.S. FDA Approves Radicava (Edaravone) to Treat ALS | 2017/05/06
10 - U.S. FDA Approves Ocrevus (Ocrelizumab) to Treat Multiple Sclerosis | 2017/03/30
11 - Researchers Urge More Transparency From FDA | 2017/03/18
12 - FDA Approves Noctiva for Frequent Night Urination Treatment | 2017/03/07
13 - FDA Approves Emflaza (Deflazacort) to Treat Duchenne Muscular Dystrophy | 2017/02/09
14 - Lawsuit Urges FDA to Protect Hair Salon Workers and Consumers from Formaldehyde | 2016/12/14
15 - FDA Approves First Drug to Treat Duchenne Muscular Dystrophy | 2016/09/20
16 - FDA Challenged to Support Claims Regarding Electronic Cigarettes | 2013/02/20
17 - Ethical Dilemmas Contribute to Weakness in FDA Postmarket Oversight | 2012/08/23
18 - Insomnia Drug Intermezzo Approved by FDA | 2011/11/25
19 - Cialis to Treat Benign Prostatic Hyperplasia Approved by FDA | 2011/10/13
20 - Boostrix for Tetanus, Diphtheria and Pertussis in Seniors | 2011/07/10
21 - FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain | 2011/06/30
22 - Global Strategy to Help Ensure Safety and Quality of Imported Products | 2011/06/20
23 - Injectable Gel to Treat Fecal Incontinence Approved by FDA | 2011/05/28
24 - Toxoplasmosis Parasite Infection Test | 2011/05/24
25 - Sutent for Rare Type of Pancreatic Cancer Approved by FDA | 2011/05/22
26 - Q Fever Test for Military Personnel Serving Overseas | 2011/05/22
27 - Edurant a New HIV Treatment Approved by FDA | 2011/05/20
28 - FDA Approves Victrelis for Hepatitis C | 2011/05/14
29 - FDA Approves Tradjenta (linagliptin) for Treatment of Type 2 Diabetes | 2011/05/03
30 - Horizant for Restless Legs Syndrome FDA Approved | 2011/04/10
31 - FDA Proposes Draft Menu and Vending Machine Labeling Requirements | 2011/04/01
32 - Treatment for a Late Stage Skin Cancer | 2011/03/28
33 - Zostavax Vaccine to Prevent Shingles - FDA Approval | 2011/03/25
34 - Edarbi for High Blood Pressure Approved by FDA | 2011/02/26
35 - Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS | 2011/02/14
36 - FDA Approves Viibryd to Treat Major Depressive Disorder | 2011/01/22
37 - Natroba (Spinosad) Head Lice Treatment for Children and Adults - FDA Approval | 2011/01/18
38 - FDA Warns Consumers Not to Use Fruta Planta Weight Loss Products | 2011/01/01
39 - FDA Approval for Axiron (testosterone) Topical Solution CIII | 2010/11/27
40 - Extension of FDA Review for Cladribine Tablets for Treatment of Relapsing Forms of Multiple Sclerosis | 2010/11/26
41 - FDA Approves Cymbalta for Chronic Musculoskeletal Pain | 2010/11/07
42 - FDA Approval of First Drug to Treat Tuberous Sclerosis Complex | 2010/10/30
43 - PRADAX Approved for for Stroke Prevention in Canadians with Atrial Fibrillation | 2010/10/27
44 - New Oral Contraceptive Also Raises Folate Levels | 2010/09/25
45 - Oral Drug to Reduce MS Relapses FDA Approved | 2010/09/22
46 - FDA Approves New Drug for Gout | 2010/09/15
47 - FDA Approves Pediatric Use of Chemical Poisoning Treatment | 2010/09/09
48 - Actavis Receives FDA Approval of Atomoxetine HCl Capsules for ADHD | 2010/09/02
49 - FDA Approves New Abortion Drug Ella as Emergency Contraceptive | 2010/08/15
50 - Public Outcry for FDA Reform | 2010/08/13
51 - FDA Approves Vaccines for 2010-2011 Influenza Season | 2010/07/31
52 - New York State Approves Quest Diagnostics Fragile X Syndrome Test | 2010/07/30
53 - Implantable Miniature Telescope Improves Sight of AMD Patients | 2010/07/08
54 - Circadin Approved in EU for Treatment of Primary Insomnia | 2010/07/05
55 - FDA Approves New Treatment for Advanced Prostate Cancer | 2010/06/18
56 - FDA Clearance of Lactate Test | 2010/06/15
57 - FDA Advisory Committee Recommends Approval of FTY720 Fingolimod for Relapsing Remitting Multiple Sclerosis | 2010/06/12
58 - FDA to Review Dental Amalgam | 2010/06/10
59 - FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women | 2010/06/01
60 - LensAR Laser System Receives FDA Clearance for Use in Cataract Surgery | 2010/05/18
61 - FDA Clearance for Redsense Safety Device for Home use During Home Hemodialysis | 2010/05/18
62 - Equal Rigor in Assessing Food Claims and Drug Approvals | 2010/05/12
63 - U.S. FDA Approves Natazia, a New Oral Contraceptive for the Prevention of Pregnancy | 2010/05/08
64 - FDA Approved VIMOVO for Arthritis Patients | 2010/05/03
65 - FDA Approval of Asclera to Treat Varicose Veins | 2010/04/24
66 - Device Manufacturers to Include Information on Pediatric Populations | 2010/03/31
67 - Once-Daily MIRAPEX ER Approved by FDA for Parkinson's Disease | 2010/03/23
68 - FDA Approval of Differin (adapalene) Lotion for Acne Treatment | 2010/03/22
Cite:
House, van, personal loans, sources and information for singles, seniors, low income families, and disabled.
Chart of health and disability awareness ribbon colors including their associated causes and meaning.